JPRN-jRCT2080222437未知3 期
Comparative Study of OPC-1085EL Ophthalmic Solution to Latanoprost Ophthalmic Solution 0.005% in Subjects with Primary Open-Angle Glaucoma or Ocular Hypertension (Phase 3 study)
适应症
试验速览
- 阶段
- 3 期
- 入组人数
- 220
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 80age old（—）
- 性别
- All
入选标准
- •Subjects with bilateral primary open-angle glaucoma or ocular hypertension
排除标准
- •Subjects with ocular conditions as defined by the protocol
研究者
相似试验
未知
3 期
Comparative Study of OPC-1085EL Ophthalmic Solution to Carteolol Hydrochloride Long-Acting Ophthalmic Solution 2% in Subjects with Primary Open-Angle Glaucoma or Ocular Hypertension (Phase 3 study)Glaucoma or ocular hypertensionJPRN-jRCT2080222438Otsuka Pharmaceutical Co., Ltd.175
已完成
1 期
Pharmacokinetic Study of OPC-1085EL Ophthalmic Solution in Healthy Male Adult VolunteersGlaucomaOcular HypertensionNCT02108288Otsuka Pharmaceutical Co., Ltd.30
已完成
3 期
Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular HypertensionGlaucomaOcular HypertensionNCT02105285Otsuka Pharmaceutical Co., Ltd.193
已完成
3 期
Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular HypertensionGlaucomaOcular HypertensionNCT02105272Otsuka Pharmaceutical Co., Ltd.237
已完成
3 期
Confirmatory Study of OPC-12759 Ophthalmic SolutionDry EyeNCT01660256Otsuka Pharmaceutical Co., Ltd.209